1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
2MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
3Department of Pharmacology and Experimental Therapy, Institute for Pharmacology and Toxicology and Interfaculty Center of Pharmacogenomics and Pharma Research Eberhard-Karls-Universität Tübingen, Tübingen 72074, Germany.
4Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
5Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
6Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
7Department of Molecular Medicine and Pathology, University of Auckland, Auckland 1142, New Zealand.
8Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
↵†To whom correspondence should be addressed. E-mail: rlw{at}mrc-lmb.cam.ac.uk (R.L.W.); jonathan.backer{at}einstein.yu.edu (J.M.B.)
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Signaling 04 Dec 2012: Vol. 5, Issue 253, pp. ra89 DOI: 10.1126/scisignal.2003264
Hashem A. Dbouk
1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
3Department of Pharmacology and Experimental Therapy, Institute for Pharmacology and Toxicology and Interfaculty Center of Pharmacogenomics and Pharma Research Eberhard-Karls-Universität Tübingen, Tübingen 72074, Germany.
3Department of Pharmacology and Experimental Therapy, Institute for Pharmacology and Toxicology and Interfaculty Center of Pharmacogenomics and Pharma Research Eberhard-Karls-Universität Tübingen, Tübingen 72074, Germany.
3Department of Pharmacology and Experimental Therapy, Institute for Pharmacology and Toxicology and Interfaculty Center of Pharmacogenomics and Pharma Research Eberhard-Karls-Universität Tübingen, Tübingen 72074, Germany.
By Hashem A. Dbouk, Oscar Vadas, Aliaksei Shymanets, John E. Burke, Rachel S. Salamon, Bassem D. Khalil, Mathew O. Barrett, Gary L. Waldo, Chinmay Surve, Christine Hsueh, Olga Perisic, Christian Harteneck, Peter R. Shepherd, T. Kendall Harden, Alan V. Smrcka, Ronald Taussig, Anne R. Bresnick, Bernd Nürnberg, Roger L. Williams, Jonathan M. Backer
Science Signaling : ra89
Blocking the activation of p110β by G proteins inhibits tumor cell proliferation.
By Hashem A. Dbouk, Oscar Vadas, Aliaksei Shymanets, John E. Burke, Rachel S. Salamon, Bassem D. Khalil, Mathew O. Barrett, Gary L. Waldo, Chinmay Surve, Christine Hsueh, Olga Perisic, Christian Harteneck, Peter R. Shepherd, T. Kendall Harden, Alan V. Smrcka, Ronald Taussig, Anne R. Bresnick, Bernd Nürnberg, Roger L. Williams, Jonathan M. Backer
Science Signaling : ra89
Blocking the activation of p110β by G proteins inhibits tumor cell proliferation.